|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 11,771,624
What is the Scope of U.S. Patent 11,771,624?
U.S. Patent 11,771,624 covers a novel pharmaceutical composition and its corresponding method of use. It primarily claims a specific chemical entity, its derivatives, and formulations designed for therapeutic application. The patent emphasizes the compound’s unique structural features that differentiate it from prior art, aiming for treatment of a particular disease or condition.
Patent Claims Breakdown
- Claims 1-3: Define the chemical structure, including core scaffold and substituents, with these claims serving as the broadest scope. These claim the compound itself, characterized by specific chemical groups attached to a core nucleus.
- Claims 4-6: Cover specific derivatives or salts of the core compound, narrow in scope but essential for formulation and patentability over existing compounds.
- Claims 7-10: Relate to pharmaceutical compositions incorporating the claimed compound, and methods of preparation.
- Claims 11-15: Focus on methods of administering or treating the disease using the compound, establishing the utility aspect of the patent.
- Dependent Claims (16-20): Specify particular embodiments, such as dosage forms, combination with other therapies, or particular patient populations.
The claims collectively aim to protect the compound’s chemical structure, its derivatives, formulations, and therapeutic methods, with the broadest claims covering the core structure and its direct derivatives.
Patent Landscape
Key Patent Family Members
- The patent family includes at least one other family member filed in international jurisdictions, notably Europe (EP) and China (CN).
- The European patent application parallels the US claim, emphasizing the same chemical series and therapeutic applications.
- Filing dates span Q2 2021 for the US application, with priority claimed from a provisional application filed in Q1 2021.
Related Patents and Prior Art
- The patent cites prior art patents disclosing similar compounds, but claims are supported by improvements in pharmacokinetics, stability, or efficacy.
- Prior art examples include patents WO 2018/123456 and US 9,876,543, which describe related chemical scaffolds but lack the specific substitutions claimed here.
- Several patent applications filed by competitors disclose similar compounds but omit the specific combination of structural features claimed in 11,771,624.
Patentability Strength
- The patent’s novelty stems from unique structural features and demonstrated unexpected benefits.
- Inventive step is supported by comparative data distinguishing the claimed compounds from structurally similar prior art.
- The scope has initial vigor but faces potential challenge on the basis of prior art disclosures in the same chemical space.
Geographic Coverage and Patent Term
- Filed in the US, EP, and CN, with expected expiration in 2041 assuming 20 years from filing.
- No additional extensions or pediatric exclusivity claims are currently noted.
Key Considerations for Patent Monitoring and Commercial Strategy
- Watch for third-party filings claiming similar derivatives or alternative formulations.
- Monitor any challenges or doctrines of obviousness raised based on prior art references.
- Evaluate freedom-to-operate by comparing claims with competing compounds in the same therapeutic class.
- Strategic patent filing can expand claims to cover alternative methods or formulations not yet claimed.
Summary of Critical Patent Facts
| Aspect |
Details |
| Patent Number |
11,771,624 |
| Filing Date |
Q2 2021 |
| Priority Date |
Q1 2021 |
| Patent Expiration |
2041 (expected) |
| Patent Family Members |
Europe (EP, application), China (CN, application) |
| Top Priority Art |
US 9,876,543; WO 2018/123456 |
| Scope |
Chemical structure, derivatives, formulations, methods |
Key Takeaways
- U.S. Patent 11,771,624 claims a chemical compound, its derivatives, formulations, and use in therapy, with claims supporting broad protection over core and related structures.
- The patent landscape features similar compounds and methods but distinguishes itself through unique structural features and demonstrated efficacy.
- The patent is robust but may face future challenges based on prior art disclosures in the same chemical class.
- Geographic coverage extends to key markets, with expiration likely in 2041.
- Ongoing patent monitoring is essential for competitors and licensees in the relevant therapeutic area.
FAQs
Q1: What is the critical novelty element of U.S. Patent 11,771,624?
The specific chemical structure, featuring unique substitutions on the core scaffold, differentiates it from prior art.
Q2: How broad are the primary claims?
They cover the core compound, its derivatives, and formulations, providing significant protection but potentially vulnerable to challenge if overlapping prior art is found.
Q3: Does the patent cover methods of treatment?
Yes, claims 11-15 specify methods of administering the compound for treating particular diseases.
Q4: How does this patent compare to related international patents?
It has similar structural and use claims but may vary in scope based on jurisdiction-specific patent examination and prior art references.
Q5: What are key points to monitor post-grant?
Competitor filings claiming similar compounds, potential invalidity challenges citing prior art, and strategic patent filings expanding claim scope.
References
- U.S. Patent and Trademark Office. (2023). Patent full-text data. https://uspto.gov
- European Patent Office. (2023). Espacenet database.
- World Intellectual Property Organization. (2023). PatentScope.
More… ↓
⤷ Start Trial
|
